Thus, a combinatorial approach of targeting TRAF4 or its downstream molecule, such as Akt with IR, would elevate the therapeutic effect of irradiation on nasopharyngeal carcinoma, which provides novel insights into rational cancer treatment. The gene discussed is TRAF4; the disease is cancer.